Iovance Biotherapeutics’ total revenue for Q2 was $60 million, which was a 93% increase year-over-year and a 22% sequential ...

Wall Street ended mixed as retail sales rose but consumer sentiment weakened, inflation expectations jumped and sectoral stocks showed sharp divergences.

Many Nasdaq stocks look overvalued right now. But this pair seem reasonably priced given their long-term earnings growth ...